E for L Aim Public Company Limited

SET:EFORL Voorraadrapport

Marktkapitalisatie: ฿599.8m

E for L Aim Inkomsten in het verleden

Verleden criteriumcontroles 0/6

E for L Aim has been growing earnings at an average annual rate of 35.3%, while the Healthcare industry saw earnings growing at 14% annually. Revenues have been declining at an average rate of 8.7% per year.

Belangrijke informatie

35.3%

Groei van de winst

37.7%

Groei van de winst per aandeel

Healthcare Groei van de industrie23.6%
Inkomstengroei-8.7%
Rendement op eigen vermogen-4.8%
Nettomarge-2.0%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe E for L Aim geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SET:EFORL Opbrengsten, kosten en inkomsten (THB Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 241,156-233850
31 Mar 241,271123960
31 Dec 231,310134040
30 Sep 231,380254140
30 Jun 231,410224370
31 Mar 231,438174380
31 Dec 221,492534290
30 Sep 221,613694240
30 Jun 221,8807164420
31 Mar 222,0897914550
31 Dec 212,1658124600
30 Sep 212,1107984680
30 Jun 211,9261954540
31 Mar 211,7611284510
31 Dec 201,667-2995030
30 Sep 201,651-5456000
30 Jun 201,706-6106770
31 Mar 201,756-6557520
31 Dec 191,921-2737550
30 Sep 192,088-3147060
30 Jun 192,114-2976730
31 Mar 192,099-2776400
31 Dec 182,060-1646840
30 Sep 182,156-9187520
30 Jun 182,222-9468040
31 Mar 182,256-9848530
31 Dec 172,474-1,1128240
30 Sep 172,845-5779630
30 Jun 173,100-6019540
31 Mar 173,494-6069780
31 Dec 163,673-6149940
30 Sep 163,710-807760
30 Jun 163,964-17780
31 Mar 164,177727650
31 Dec 154,5042107260
30 Sep 154,0762367070
30 Jun 153,3002865500
31 Mar 152,4213163610
31 Dec 141,4502562420
30 Sep 148612071240
30 Jun 14553128880
31 Mar 1434273660
31 Dec 1315826390

Kwaliteitswinsten: EFORL is currently unprofitable.

Groeiende winstmarge: EFORL is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: EFORL is unprofitable, but has reduced losses over the past 5 years at a rate of 35.3% per year.

Versnelling van de groei: Unable to compare EFORL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: EFORL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (16.7%).


Rendement op eigen vermogen

Hoge ROE: EFORL has a negative Return on Equity (-4.75%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden